kras nsclc: prevalence and the evolution of treatment - 2022 program: targeted therapies forum
Published 1 year ago • 9 plays • Length 8:09Download video MP4
Download video MP3
Similar videos
-
2:45
kras mutations in advanced nsclc - 2022 program: targeted therapies forum - english
-
3:21
treatment timelines for kras nsclc - 2022 program: targeted therapies forum - english
-
6:55
treatment strategies for kras nsclc - 2022 program: targeted therapies forum
-
5:35
progression on sotorasib with kras nsclc - 2022 program: targeted therapies forum
-
4:31
types of biopsies for kras nsclc - 2022 program: targeted therapies forum
-
7:20
treatment of her2 nsclc - 2022 program: targeted therapies forum
-
2:49
treatments for ret nsclc: selpercatinib vs. pralsetinib - 2022 program: targeted therapies forum
-
10:03
kras nsclc: details and diagnosis - targeted therapies in lung cancer 2023
-
4:04
challenges of targeted kras treatment & current treatments - targeted therapies in lung cancer 2023
-
4:40
ntrk nsclc: treatment options and side effects - targeted therapies in lung cancer 2023
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
2:34
grace targeted therapies lung cancer 2021 - recommended firstline treatment for kras k12c?
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
2:56
barriers to drug development for kras g12c nsclc - targeted therapies in lung cancer 2023
-
3:09
grace targeted therapies lung cancer 2021 - best treatment patient with a designated kras mutation
-
3:59
grace targeted therapies lung cancer 2021 - treatment options available for kras k12c mutation?
-
3:56
kras g12c inhibitors versus chemotherapy in second line - targeted therapies in lung cancer 2023